GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 125 filers reported holding GOSSAMER BIO INC in Q4 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8,576 | -82.5% | 3,952 | -3.5% | 0.00% | -100.0% |
| Q3 2022 | $49,058 | +43.1% | 4,095 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $34,275 | -3.6% | 4,095 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $35,545 | -81.3% | 4,095 | -75.6% | 0.00% | -66.7% |
| Q4 2021 | $189,963 | -5.4% | 16,796 | +5.2% | 0.00% | 0.0% |
| Q3 2021 | $200,755 | +185.3% | 15,971 | +84.3% | 0.00% | +200.0% |
| Q2 2021 | $70,360 | -50.6% | 8,665 | -43.7% | 0.00% | -50.0% |
| Q1 2021 | $142,487 | -13.3% | 15,404 | -9.4% | 0.00% | 0.0% |
| Q4 2020 | $164,332 | -22.1% | 16,994 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $210,896 | +12.1% | 16,994 | +17.4% | 0.00% | +33.3% |
| Q2 2020 | $188,214 | +33.7% | 14,478 | +4.4% | 0.00% | 0.0% |
| Q1 2020 | $140,821 | -32.3% | 13,874 | +4.3% | 0.00% | 0.0% |
| Q4 2019 | $207,942 | -13.1% | 13,304 | -6.7% | 0.00% | -25.0% |
| Q3 2019 | $239,425 | +585.0% | 14,260 | +804.8% | 0.00% | +300.0% |
| Q2 2019 | $34,955 | – | 1,576 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |